ZYDUSWELL Zydus Wellness Q4 FY25 results (Jan–Mar 2025) and concall
Zydus Wellness reported robust Q4 and FY25 results, driven by strong volume and value growth across both Personal Care and Food & Nutrition segments. The company achieved significant margin expansion and strong cash generation, while also announcing a dividend increase and stock split. Challenges included input cost volatility and regional demand fluctuations, but strategic acquisitions like Rite Bite are performing well and contributing to growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 493 | 462 | 913 |
| EBITDA | 20 | 15 | 190 |
| Net profit | 21 | 6 | 172 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
